WHO ICTRP trial
Macular Pigment and Glaucoma Trial
ISRCTN56985060 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN56985060 |
|---|---|
| Public title | Macular Pigment and Glaucoma Trial |
| Scientific title | Macular Pigment and Glaucoma Trial: a placebo-controlled, double-masked study |
| Primary sponsor | The Howard Foundation (UK) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | Ireland |
| Conditions | Glaucoma and disability glare Eye Diseases Glaucoma, unspecified |
| Interventions | 120 glaucoma participants Treatment arm - MacuShield® (N=60) Placebo arm (N=60) Duration of intervention: 6 months At baseline, all glaucoma participants will undergo detailed vision assessments such as visual acuity, slit- lamp… |
| Registration date | Feb 10, 2013 |
| Target size | 180 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: